Synergistic anti-tumor effects with dabigatran etexilate and cisplatin in a murine ovarian cancer model

被引：0
|
作者：
Alexander, E. [1 ]
Hayes, C. [1 ]
Minton, A. [1 ]
Jain, K. B. [1 ]
Goss, A. [2 ]
Van Ryn, J. [3 ]
Gilmour, S. [1 ]
机构：
[1] Lankenau Inst Med Res, Wynnewood, PA USA
[2] Boehringer Ingelheim Pharmaceut Inc, Dept CardioMetab Dis Res, Ridgefield, CT 06877 USA
[3] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetab Dis Res, Biberach, Germany
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OR356
引用
收藏
页码：232 / 232
页数：1
相关论文
共 50 条
  • [1] Synergistic anti-cancer effects with dabigatran etexilate and cisplatin or cyclophosphamide
    Gilmour, S. K.
    Hayes, C. S.
    Shicora, A.
    Goss, A. M.
    Van Ryn, J.
    Gilmour, S. K.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 154 - 154
  • [2] Synergistic anti-tumor effects of dabigatran etexilate and cyclophosphamide co-treatment are associated with decreased circulating tissue factor positive microparticles
    Alexander, Eric T.
    Minton, Allyson R.
    Hayes, Candace S.
    Goss, Ashley
    Van Ryn, Joanne
    Gilmour, Susan K.
    [J]. CANCER RESEARCH, 2015, 75
  • [3] Efficacy of Dabigatran Etexilate in a Murine Model of Cancer Associated Thrombosis
    Al-Mosuli, Yusra
    Vanryn, Joanne
    Lemarie, Catherine
    Blostein, Mark
    [J]. BLOOD, 2016, 128 (22)
  • [4] Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin
    Zhao, Sufen
    Ye, Gang
    Fu, Guodong
    Cheng, Jian-Xin
    Yang, Burton B.
    Peng, Chun
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (05) : 1319 - 1327
  • [5] Gemcitabine and checkpoint blockade exhibit synergistic anti-tumor effects in a model of murine lung carcinoma
    Du, Bin
    Wen, Xiaojiao
    Wang, Yao
    Lin, Mengxin
    Lai, Jinhuo
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 86
  • [6] Synergistic anti-tumor effects of melatonin and PUFAs from walnuts in a murine mammary adenocarcinoma model
    Garcia, Carolina P.
    Lamarque, Alicia L.
    Comba, Andrea
    Berra, Maria A.
    Silva, Renata A.
    Labuckas, Diana O.
    Das, Undurti N.
    Eynard, Aldo R.
    Pasqualini, Maria E.
    [J]. NUTRITION, 2015, 31 (04) : 570 - 577
  • [7] lncRNA LOC102724169 plus cisplatin exhibit the synergistic anti-tumor effect in ovarian cancer with chronic stress
    Zhou, Xiaofang
    Liu, Mu
    Deng, Guanming
    Chen, Le
    Sun, Lijuan
    Zhang, Yun
    Luo, Chenhui
    Tang, Jie
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 24 : 294 - 309
  • [8] Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer
    Wen, Wei
    Han, Ernest S.
    Dellinger, Thanh H.
    Lu, Leander X.
    Wu, Jun
    Jove, Richard
    Yim, John H.
    [J]. CANCERS, 2020, 12 (09) : 1 - 17
  • [9] Blockade of HB-EGF induces synergistic anti-tumor effects with taxol in ovarian cancer.
    Miyamoto, Shingo
    Yagi, Hiroshi
    Yotsumoto, Fusanori
    Sonoda, Kenzo
    Hachisuga, Toru
    Kawarabayashi, Tatsuhiko
    Mekada, Eisuke
    [J]. CANCER RESEARCH, 2006, 66 (08)
  • [10] Cisplatin-RNAi nanotherapeutics for synergistic anti-tumor activity
    Xu, Xiaoyang
    Zhang, Xueqing
    Xie, Kun
    Walker, Graham
    Farokhzad, Omid
    [J]. CANCER RESEARCH, 2014, 74 (19)
12345